14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.265 $5.95 Thursday, 2nd May 2024 WINT stock ended at $4.33. This is 3.56% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 10.71% from a day low at $4.20 to a day high of $4.65.
90 days $0.265 $5.95
52 weeks $0.265 $5.95

Historical Windtree Therapeutics Inc prices

Date Open High Low Close Volume
May 04, 2023 $1.55 $1.60 $1.49 $1.53 624 109
May 03, 2023 $1.50 $1.66 $1.36 $1.60 2 104 028
May 02, 2023 $1.49 $1.49 $1.36 $1.36 358 267
May 01, 2023 $1.52 $1.54 $1.45 $1.47 490 751
Apr 28, 2023 $1.64 $1.68 $1.58 $1.64 379 847
Apr 27, 2023 $1.82 $1.82 $1.61 $1.69 856 389
Apr 26, 2023 $1.81 $1.81 $1.57 $1.76 945 554
Apr 25, 2023 $2.16 $2.16 $1.84 $1.86 1 183 748
Apr 24, 2023 $2.21 $2.23 $2.01 $2.12 1 221 555
Apr 21, 2023 $2.47 $2.47 $2.13 $2.21 2 678 713
Apr 20, 2023 $2.40 $2.50 $2.25 $2.37 7 515 312
Apr 19, 2023 $7.55 $7.79 $5.44 $5.60 3 310 004
Apr 18, 2023 $7.29 $11.98 $6.49 $6.66 6 108 911
Apr 17, 2023 $4.75 $18.48 $4.65 $8.27 12 001 292
Apr 14, 2023 $4.46 $5.17 $4.33 $4.38 137 316
Apr 13, 2023 $4.41 $4.85 $4.41 $4.52 60 321
Apr 12, 2023 $4.69 $4.89 $4.42 $4.48 60 000
Apr 11, 2023 $4.60 $4.70 $4.50 $4.52 36 563
Apr 10, 2023 $4.81 $4.89 $4.50 $4.74 49 388
Apr 06, 2023 $5.02 $5.19 $4.87 $4.90 31 860
Apr 05, 2023 $4.77 $6.28 $4.71 $5.18 445 026
Apr 04, 2023 $5.03 $5.15 $4.62 $4.62 58 967
Apr 03, 2023 $4.84 $6.38 $4.71 $5.16 478 112
Mar 31, 2023 $5.18 $5.70 $4.83 $4.99 239 964
Mar 30, 2023 $4.55 $7.50 $4.52 $5.58 1 205 172
Click to get the best stock tips daily for free!

About Windtree Therapeutics Inc

Windtree Therapeutics Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart failure, as well as in Phase IIa clinical trial for the treatment of early cardiogenic shock; AEROSURF,... WINT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT